Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Sanara MedTech (SMTI) Return on Sales (2016 - 2025)

Historic Return on Sales for Sanara MedTech (SMTI) over the last 15 years, with Q3 2025 value amounting to 1.19%.

  • Sanara MedTech's Return on Sales fell 10600.0% to 1.19% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.43%, marking a year-over-year decrease of 3200.0%. This contributed to the annual value of 0.11% for FY2024, which is 500.0% down from last year.
  • Per Sanara MedTech's latest filing, its Return on Sales stood at 1.19% for Q3 2025, which was down 10600.0% from 0.07% recorded in Q2 2025.
  • Sanara MedTech's 5-year Return on Sales high stood at 0.08% for Q2 2022, and its period low was 1.19% during Q3 2025.
  • Over the past 5 years, Sanara MedTech's median Return on Sales value was 0.14% (recorded in 2025), while the average stood at 0.22%.
  • As far as peak fluctuations go, Sanara MedTech's Return on Sales soared by 2800bps in 2023, and later tumbled by -10600bps in 2025.
  • Over the past 5 years, Sanara MedTech's Return on Sales (Quarter) stood at 0.51% in 2021, then soared by 46bps to 0.27% in 2022, then surged by 95bps to 0.01% in 2023, then crashed by -1694bps to 0.27% in 2024, then tumbled by -346bps to 1.19% in 2025.
  • Its last three reported values are 1.19% in Q3 2025, 0.07% for Q2 2025, and 0.14% during Q1 2025.